- Walgreens expanding scope of retail pharmacy experience and services heading into fiscal 2014
- On the heels of Q3, Walgreens outlines shift in front-end strategy and pharmacy tailwinds looking forward
- Bloomberg: Greg Wasson joins thought leaders to discuss the state of health care in the United States
- CNNMoney sits down with Walgreens chief to discuss future of health care and what it means for pharmacy
- Walgreens, Rite Aid join outcry over Boston Rolling Stone cover
DEERFIELD, Ill. — Walgreens on Monday reported July sales of $6 billion, an increase of 8%. Sales in comparable stores increased by 6.3% in July.
Calendar 2013 sales to date were $42 billion, an increase of 3.4%, while fiscal year-to-date sales totaled $66.1 billion, up 0.4%..
July pharmacy sales increased by 9.9%, while comparable-store pharmacy sales increased 8.8% and increased by a calendar day-shift adjusted 6.6%. This year's July had one additional Wednesday and one fewer Sunday compared with July 2012. Calendar day shifts positively impacted pharmacy sales in comparable stores by 220 basis points. Calendar day-shift adjusted comparable-store pharmacy sales were negatively impacted by 280 basis points due to generic drug introductions in the last 12 months.
Pharmacy sales accounted for 64.6% of total sales for the month, Walgreens reported.
Prescriptions filled at comparable stores increased by 9.5% in July and increased 7.3% on a calendar day-shift adjusted basis.
Total front-end sales increased 3.6% compared with the same month in fiscal 2012, while comparable store front-end sales increased 2.3%. Customer traffic in comparable stores decreased 1.2% and basket size increased 3.5%.
Registrations for Walgreens Balance Rewards loyalty program, which launched in September 2012, totaled 79 million through July.
Walgreens opened nine stores during July, including one relocation, and closed one.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.